Trending Now
Curis, Inc. (NASDAQ: CRIS) Recently Announced Its Partners’ Publication on Emarvusatib
Curis, Inc. (NASDAQ: CRIS) recently announced the publication of a report created by the company's collaborators. The school of Medicine from Washington University authored...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Says Preclinical Results of TNX-1900 Are...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announces says it is ready to make public the results from preclinical results of TNX-1900 (oxytocin solution for intranasal...
MAKE IT MODERN
LATEST REVIEWS
Sensus Healthcare (NASDAQ: SRTS): A Strong Start to 2024 with Impressive...
Sensus Healthcare, Inc. (NASDAQ: SRTS), a leader in non-invasive and minimally invasive treatments for both oncological and non-oncological conditions, has reported a...
MAKE IT MODERN
PERFORMANCE TRAINING
MacroGenics Inc. (NASDAQ:MGNX) Announce Publication Of Research Supporting flotetuzumab Study in AML Patients In...
MacroGenics Inc. (NASDAQ:MGNX) has announced the publication of research in the journal of Science Translational medicine that supports the company's pivotal flotetuzumab study in...
Mangoceuticals (NASDAQ:MGRX) Unlocking Value By Empowering America’s Wellness
Men face a myriad of issues, most of which they shy to talk about. However, rising awareness and increased focus on personal...
Adaptimmune Therapeutics plc (NASDAQ: ADAP) Partner with Genentech to Develop and Commercialize Allogeneic Cell...
Cancer is one of the many devastating conditions across the globe which hundreds of households have had to live with due to lack of...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Releases Data Of AB-729 90 Mg Single-Dose In HBV
Arbutus Biopharma Corporation (NASDAQ:ABUS) has reported on-going positive data from its continuing Phase 1a/1b AB-729 clinical trial. AB-729 is the company’s novel GaINAc delivered...
Ocugen Inc (NASDAQ: OCGN) Recently Issued an Update to Its Shareholders Regarding Its Latest...
Ocugen Inc (NASDAQ: OCGN) recently announced transforming its distinct platform by instituting a stage 3 cell treatment identified as the NeoCart. The company also...
MAKE IT MODERN
